Johnson & Johnson Innovation seeks to positively impact human health through innovation. Their mission is to create the leading global innovation network with the aim to generate potential transformational healthcare solutions through value-creating partnerships and collaborations. They work side-by-side with innovators and entrepreneurs, helping them to realize their dreams and providing support throughout their journey. Through a robust exchange of ideas and resources, the ultimate aim is to help improve people’s lives around the world. Their expertise spans multiple sectors: consumer, medical devices, pharmaceuticals, digital health and global public health.
Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, the Johnson & Johnson Innovation team is looking to present its external collaboration model and meet life sciences start-ups across Europe through virtual events and one-to-one sessions.
This event will target the Benelux ecosystem (Belgium, the Netherlands and Luxemburg). The event will include an open presentation on the Johnson & Johnson Innovation model on 3 March, followed by one-to-one partnering meetings with selected companies on 3 and 4 March.